Tue Mar 18, 2025 3:24 pm
2025-Phillips et al-Oncoimmunology
"XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial"
Maggie J Phillips, Olatunji B Alese, Natalie K Horvat, Emily Greene, Olumide B Gbolahan, Kathleen Coleman, Deon B Doxie, Vaunita Parihar, Zaid K Mahdi, Ashley McCook-Veal, Jeffrey M Switchenko, Maria Diab, Cameron J Herting, Chrystal M Paulos, Bassel F El-Rayes, Gregory B Lesinski
Oncoimmunology. 2025, 14, 2475620
https://doi.org/10.1080/2162402x.2025.2475620
- no dataset accession given
Maggie J Phillips, Olatunji B Alese, Natalie K Horvat, Emily Greene, Olumide B Gbolahan, Kathleen Coleman, Deon B Doxie, Vaunita Parihar, Zaid K Mahdi, Ashley McCook-Veal, Jeffrey M Switchenko, Maria Diab, Cameron J Herting, Chrystal M Paulos, Bassel F El-Rayes, Gregory B Lesinski
Oncoimmunology. 2025, 14, 2475620
https://doi.org/10.1080/2162402x.2025.2475620
- no dataset accession given